OmnEcoil Device
Prostate Cancer Diagnosis
Development/PrototypeActive
Key Facts
Indication
Prostate Cancer Diagnosis
Phase
Development/Prototype
Status
Active
Company
About OmnEcoil Instruments
OmnEcoil Instruments is a private, pre-revenue medical device startup targeting the prostate cancer diagnostics market. Its core innovation, the OmnEcoil, is an integrated endorectal coil and biopsy guidance device that enables high-quality MRI imaging and MRI-targeted biopsy in one session, potentially improving diagnostic accuracy and patient comfort. The company is led by an experienced CEO with a track record in financing and exits, and is supported by a key scientific inventor who is a leading expert in prostate MRI. While the technology is promising, it faces challenges in market adoption, reimbursement, and competition from existing fusion biopsy systems.
View full company profileOther Prostate Cancer Diagnosis Drugs
| Drug | Company | Phase |
|---|---|---|
| Triopsy Biopsy System | Triopsy | Commercial |
| QP-Prostate | Quibim | Commercial |
| Promaxo MRI System for Prostate Biopsy | Promaxo | Approved |